dupilumab

Atopic Dermatitis
Biotech

Pfizer beats blockbuster Dupixent in phase 3 eczema trial

Pfizer chalked up an efficacy win over the blockbuster incumbent without sharing key details of safety data that could shape the category.
Nick Paul Taylor Aug 30, 2021 8:55am
Pascal Soriot

AstraZeneca drops tezepelumab from atopic dermatitis pipeline

Jul 29, 2021 6:19am
Albert Bourla incoming Pfizer CEO

Pfizer's abrocitinib aces 5th phase 3 on route to FDA decision

Nov 11, 2020 8:05am
Aslan CMO Kenneth Kobayashi

Aslan hopes to roar again as Dupixent rival test resumes

Aug 24, 2020 7:10am
Pfizer headquarters logo sign

Safety issues for Pfizer's Dupixent rival may hamper uptake

Jun 4, 2020 11:10am
Old eye

Could Dupixent also treat age-related macular degeneration?

May 7, 2020 8:15am